Stent Grafts Market - Global Forecast 2025-2032

The stent grafts market is evolving rapidly, shaped by continuous innovation in vascular medicine and influenced by shifting global trade conditions. Leaders in the medical device sector must understand both the emerging technologies and regulatory changes driving growth and competitive strategy in this complex landscape.

Stent Grafts Market Snapshot

The stent grafts market grew from USD 5.72 billion in 2024 to USD 6.30 billion in 2025, and is projected to continue expanding at a compound annual growth rate (CAGR) of 10.14%, reaching USD 12.40 billion by 2032. Fueled by rising cardiovascular disease prevalence and advances in minimally invasive vascular procedures, market activity is intensifying globally. Innovations in device design, material science, and imaging technologies are not only transforming patient outcomes but also redefining procurement and supply chain strategies for leading manufacturers and providers. Competitive pressures are increasingly apparent, as industry players reposition portfolios to address evolving clinical needs across established and growth markets.

Scope & Segmentation

• Product Types: Aortic stent grafts (including abdominal and thoracic aneurysm applications), Peripheral stent grafts.
• Indications: Aneurysm repair (abdominal, thoracic), Peripheral vascular disease interventions.
• End Users: Hospitals, Ambulatory surgical centers.
• Delivery Mechanisms: Balloon expandable, Self expandable stent graft systems.
• Material Types: Expanded polytetrafluoroethylene (ePTFE), Polyester fabric grafts.
• Configuration Options: Bifurcated, Branched, Straight device formats.
• Regional Coverage: Americas (North America: United States, Canada, Mexico; Latin America: Brazil, Argentina, Chile, Colombia, Peru), EMEA (Europe: United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland; Middle East: United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel; Africa: South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan).
• Technology Trends: Imaging integration, digital navigation, hybrid scaffold designs, biocompatible material advances, and remote patient monitoring.
• Key Companies: Medtronic plc, W. L. Gore & Associates, Inc., Terumo Corporation, Cook Medical LLC, Boston Scientific Corporation, Endologix, LLC, Jotec GmbH, MicroPort Scientific Corporation, B. Braun Melsungen AG, Bentley InnoMed GmbH.

Key Takeaways for Senior Decision-Makers

• Surge in demand for minimally invasive solutions is expanding eligible patient pools and shifting standard-of-care from open surgery to image-guided techniques.
• Investment in advanced stent architectures and graft materials is facilitating personalized device design, improving safety and patient outcomes.
• Refinements in delivery systems and digital tools are streamlining procedural workflows and enhancing operator adoption in both high-volume hospitals and ambulatory centers.
• Regional market access depends heavily on regulatory alignment and localized clinical evidence, especially in EMEA and Asia-Pacific, driving joint ventures and technology transfers.
• Competitive advantage accrues to companies embracing collaborative R&D with academic and contract research partners to accelerate clinical validation and expand therapeutic indications.
• Supply chain agility and risk mitigation have become decisive factors as organizations respond to evolving tariff regulations and potential logistics disruptions.

Tariff Impact: Strategic Supply Chain Reassessment

Recent United States tariff revisions have driven device manufacturers to reevaluate sourcing, production, and logistics strategies. The resultant increase in component and material costs has triggered a trend toward near-sourcing, regional supplier partnerships, and dual-sourcing to safeguard against possible disruptions. Market leaders are leveraging demand forecasting and buffer inventory strategies to maintain reliability for healthcare providers, with local manufacturing incentives under consideration in several regions.

Methodology & Data Sources

This report synthesizes insights from peer-reviewed journals, regulatory databases, and patent analyses. Findings were validated via structured interviews with vascular surgeons, procurement experts, and key opinion leaders to ensure diverse perspectives on industry trends and challenges. Advanced modeling and triangulation techniques underpin the reliability of all market projections and segmentation analysis.

Why This Report Matters to Decision-Makers

• Enables precise strategic planning by illuminating market trends, segmentation opportunities, and technology trajectories relevant to executive priorities.
• Highlights emerging risks and operational challenges, including tariff-driven cost volatility and supply chain vulnerabilities that affect budgeting and procurement.
• Offers competitive benchmarking and identifies collaborative pathways that can inform investment, expansion, and go-to-market decisions regionally and globally.

Conclusion

The stent grafts market is shaped by a convergence of innovation, clinical need, and global regulatory shifts. By leveraging this detailed analysis, industry leaders can adapt confidently to evolving requirements and proactively secure growth in a highly dynamic sector.